UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 million

Reuters2026/08/24 21:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

UroGen Pharma Chief Medical Officer Mark Schoenberg sold 60,677 ordinary shares on Aug. 20, 2026.
Sale priced at USD 47.05 per share on a weighted-average basis.
Post-transaction holding totaled 59,086 ordinary shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Urogen Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-028840), on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

UroGen Pharma CMO Mark Schoenberg sells 60,677 common shares for $2.86 million

You may also like

Crypto prices